Virtus Advisers LLC Takes $348,000 Position in Teladoc Health, Inc. $TDOC

Key Points

• Virtus Advisers LLC purchased 43,760 shares of Teladoc Health, Inc. for approximately $348,000 in the first quarter, reflecting growing interest in the stock.
• Multiple institutional investors have increased their stakes in Teladoc, with Golden State Wealth Management LLC and National Bank of Canada FI boosting their holdings significantly during the same period.
• Teladoc's recent quarterly earnings exceeded expectations, reporting a loss per share of ($0.19) against an anticipated ($0.27), with revenue reaching $631.90 million, albeit down 1.6% year-over-year.

Virtus Advisers LLC acquired a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 43,760 shares of the health services provider's stock, valued at approximately $348,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in Teladoc Health by 7.0% in the first quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock valued at $157,229,000 after buying an additional 1,289,183 shares in the last quarter. Point72 Asset Management L.P. increased its holdings in Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after buying an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. increased its holdings in Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after buying an additional 2,331,000 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Teladoc Health by 0.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,531,492 shares of the health services provider's stock valued at $32,104,000 after buying an additional 8,890 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Teladoc Health by 5.2% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,571,673 shares of the health services provider's stock valued at $20,471,000 after buying an additional 127,960 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 3,958 shares of the stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the sale, the insider owned 17,645 shares in the company, valued at approximately $121,044.70. This represents a 18.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Fernando M. Rodrigues sold 4,174 shares of the stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total transaction of $28,842.34. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,656 shares of company stock worth $128,189. Insiders own 0.58% of the company's stock.

Teladoc Health Price Performance

TDOC stock traded down $0.15 during mid-day trading on Friday, reaching $7.74. The company's stock had a trading volume of 3,533,595 shares, compared to its average volume of 6,028,472. The stock has a market cap of $1.37 billion, a PE ratio of -6.50 and a beta of 1.76. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company's 50 day moving average is $7.81 and its two-hundred day moving average is $8.03.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. Teladoc Health's quarterly revenue was down 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Equities research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. Mizuho assumed coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 price target for the company. Bank of America reduced their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th. Wells Fargo & Company reduced their price target on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Evercore ISI upped their price target on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Finally, Truist Financial reduced their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research report on Tuesday, May 27th. Six equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $9.80.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.